Drug-induced hypoglycemia without coma
ICD-10 E16.0 is a billable code used to indicate a diagnosis of drug-induced hypoglycemia without coma.
Drug-induced hypoglycemia without coma refers to a condition where a patient experiences low blood glucose levels due to the administration of certain medications, without the presence of a coma. This condition is particularly relevant in patients with diabetes who are treated with insulin or oral hypoglycemic agents. The hypoglycemic episode can manifest with symptoms such as sweating, tremors, palpitations, and confusion. It is crucial to differentiate this condition from other causes of hypoglycemia, such as endogenous hyperinsulinism or pancreatic islet disorders, which may require different management strategies. The pathophysiology involves an imbalance in glucose metabolism, where the pharmacological effects of the drugs lead to excessive insulin secretion or increased sensitivity to insulin, resulting in decreased blood glucose levels. Proper management includes prompt recognition of symptoms, administration of glucose, and adjustment of medication regimens to prevent recurrence.
Detailed medication history, including dosages and timing of administration.
Patients with diabetes experiencing hypoglycemia after insulin administration.
Ensure that the documentation clearly states the cause of hypoglycemia is drug-induced.
Comprehensive review of patient history and current medications.
Patients presenting with symptoms of hypoglycemia without a known history of diabetes.
Documenting the clinical context and ruling out other causes of hypoglycemia.
Used in conjunction with E16.0 to monitor blood glucose levels.
Document the reason for testing and the patient's clinical status.
Endocrinologists may require more detailed documentation of glucose monitoring.
Common medications include insulin, sulfonylureas, and meglitinides. It's important to review the patient's medication list to identify potential culprits.
